The techniques provided by modern molecular biology have made it possible to rapidly clone and sequence new proteins at a rate that has rapidly outpaced our ability to perform structure-activity analysis using conventional methods. Some of these proteins have significant therapeutic potential. Interleukin-2 has been a prototypical example. Although it has been only five years since the CDNA sequence of IL-2 was reported, recombinant IL-2 is already being used clinically in cancer and AIDS trials and is under investigition as an adjuvant and linked to diptheria toxin, as an immunosuppressant. Although structure-function analysis of IL-2 has been attempted with a multitude of modern techniques, the specific receptor binding region remain unidentified. To achieve the long term goals of the production of IL-2 agonists and antagonists and the elucidation of the novel IL-2 receptor system, we have pursued a rational protein design strategy. Based on a computer generated model and working in a semi-synthetic system, we have begun to utilize design principles successfully employed by Kaiser and others in small peptide systems for the analysis and design of a real protein.
The specific aims of this investigation are: 1) to explore the critical biophysical parameters governing stability of secondary and tertiary conformation of IL-2; 2) to alter the binding conformation of IL-2 by manipulating these interactions thus generating agonists and antogonists an 3) to utilize these mutants to elucidate the novel IL-2-multi component receptor interaction. To accomplish these goals, cassette, multiple cassette and site directed mutagenesis will be employed on a custom synthetic IL-2 gene. The mutants will be isolated, refolded and purified. They will be characterized biochemically to ascertain purity and confirm the presence of the desired mutations biochemically to monitor conformation, stability and folding characteristics and biologically to quantify bioactivity and binding to each of the receptor proteins on cell lines and normal T cells. This study will not only generate agonists and antagonists for IL-2 based on protein design principles, but should also contribute to the understanding of folding for this class of proteins and provide fundamental knowledge concerning ligandreceptor interactions within the immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023398-08
Application #
3135438
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1986-07-01
Project End
1994-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
8
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Lee, B L; Ciardelli, T L (1997) Structural modifications of interleukin-2 at positions 47 and 65. Biochem Biophys Res Commun 233:309-15
Chang, D Z; Wu, Z; Ciardelli, T L (1996) A point mutation in interleukin-2 that alters ligand internalization. J Biol Chem 271:13349-55
Chang, D Z; Tasayco, M L; Ciardelli, T L (1995) Structural analogs of interleukin-2: a point mutation that facilitates biological response. Mol Pharmacol 47:206-11
Nielsen, O H; Ciardelli, T; Wu, Z et al. (1995) Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. Am J Gastroenterol 90:1301-6
Berndt, W G; Chang, D Z; Smith, K A et al. (1994) Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency. Biochemistry 33:6571-7
Sana, T R; Wu, Z; Smith, K A et al. (1994) Expression and ligand binding characterization of the beta-subunit (p75) ectodomain of the interleukin-2 receptor. Biochemistry 33:5838-45
Wu, Z; Eaton, S F; Laue, T M et al. (1994) Coiled-coil molecular recognition: directed solution assembly of receptor ectodomains. Protein Eng 7:1137-44
Buchli, P; Ciardelli, T (1993) Structural and biologic properties of a human aspartic acid-126 interleukin-2 analog. Arch Biochem Biophys 307:411-5
Landgraf, B E; Goldstein, B; Williams, D P et al. (1992) Recombinant interleukin-2 analogs. Dynamic probes for receptor structure. J Biol Chem 267:18511-9
Landgraf, B E; Williams, D P; Murphy, J R et al. (1991) Conformational perturbation of interleukin-2: a strategy for the design of cytokine analogs. Proteins 9:207-16

Showing the most recent 10 out of 11 publications